With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

Standard

With a Little Help From My Friends : the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease. / Nyvad, Jakob; Lerman, Amir; Lerman, Lilach O.

In: Hypertension (Dallas, Tex. : 1979), Vol. 79, No. 4, 04.2022, p. 717-725.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Nyvad J, Lerman A, Lerman LO. With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease. Hypertension (Dallas, Tex. : 1979). 2022 Apr;79(4):717-725. Epub 2022 Feb 9. doi: 10.1161/HYPERTENSIONAHA.121.17960

Author

Nyvad, Jakob ; Lerman, Amir ; Lerman, Lilach O. / With a Little Help From My Friends : the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease. In: Hypertension (Dallas, Tex. : 1979). 2022 ; Vol. 79, No. 4. pp. 717-725.

Bibtex

@article{92a94cd4cca14b13b3f7b5c3c225b7b0,
title = "With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease",
abstract = "The collateral circulation can adapt to bypass major arteries with limited flow and serves a crucial protective role in coronary, cerebral, and peripheral arterial disease. Emerging evidence indicates that the renal collateral circulation can similarly adapt and thereby limit kidney ischemia in atherosclerotic renovascular disease. These adaptations predominantly include recruitment of preexisting microvessels for arteriogenesis, with de novo vessel formation playing a limited role. Yet, adaptations of the renal collateral circulation in renovascular disease are often insufficient to fully compensate for the limited flow within an obstructed renal artery and may be hampered by the severity of obstruction or patient comorbidities. Experimental strategies have attempted to circumvent limitations of collateral formation and improve the prognosis of patients with various ischemic vascular territories. These have included pharmacological approaches such as endothelial growth factors, renin-angiotensin-aldosterone system blockade, and If-channel-blockers, as well as interventions like preconditioning, exercise, enhanced external counter-pulsation, and low-energy shock-wave therapy. However, few of these strategies have been implemented in atherosclerotic renovascular disease. This review summarizes current understanding regarding the development of renal collateral circulation in atherosclerotic renovascular disease. Studies are needed to apply lessons learned in other vascular beds in the setting of atherosclerotic renovascular disease to develop new treatment regimens for this patient group.",
keywords = "atherosclerosis, collateral circulation, kidney, prognosis, renal artery",
author = "Jakob Nyvad and Amir Lerman and Lerman, {Lilach O}",
year = "2022",
month = apr,
doi = "10.1161/HYPERTENSIONAHA.121.17960",
language = "English",
volume = "79",
pages = "717--725",
journal = "Hypertension",
issn = "0194-911X",
publisher = "LIPPINCOTT WILLIAMS & WILKINS",
number = "4",

}

RIS

TY - JOUR

T1 - With a Little Help From My Friends

T2 - the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease

AU - Nyvad, Jakob

AU - Lerman, Amir

AU - Lerman, Lilach O

PY - 2022/4

Y1 - 2022/4

N2 - The collateral circulation can adapt to bypass major arteries with limited flow and serves a crucial protective role in coronary, cerebral, and peripheral arterial disease. Emerging evidence indicates that the renal collateral circulation can similarly adapt and thereby limit kidney ischemia in atherosclerotic renovascular disease. These adaptations predominantly include recruitment of preexisting microvessels for arteriogenesis, with de novo vessel formation playing a limited role. Yet, adaptations of the renal collateral circulation in renovascular disease are often insufficient to fully compensate for the limited flow within an obstructed renal artery and may be hampered by the severity of obstruction or patient comorbidities. Experimental strategies have attempted to circumvent limitations of collateral formation and improve the prognosis of patients with various ischemic vascular territories. These have included pharmacological approaches such as endothelial growth factors, renin-angiotensin-aldosterone system blockade, and If-channel-blockers, as well as interventions like preconditioning, exercise, enhanced external counter-pulsation, and low-energy shock-wave therapy. However, few of these strategies have been implemented in atherosclerotic renovascular disease. This review summarizes current understanding regarding the development of renal collateral circulation in atherosclerotic renovascular disease. Studies are needed to apply lessons learned in other vascular beds in the setting of atherosclerotic renovascular disease to develop new treatment regimens for this patient group.

AB - The collateral circulation can adapt to bypass major arteries with limited flow and serves a crucial protective role in coronary, cerebral, and peripheral arterial disease. Emerging evidence indicates that the renal collateral circulation can similarly adapt and thereby limit kidney ischemia in atherosclerotic renovascular disease. These adaptations predominantly include recruitment of preexisting microvessels for arteriogenesis, with de novo vessel formation playing a limited role. Yet, adaptations of the renal collateral circulation in renovascular disease are often insufficient to fully compensate for the limited flow within an obstructed renal artery and may be hampered by the severity of obstruction or patient comorbidities. Experimental strategies have attempted to circumvent limitations of collateral formation and improve the prognosis of patients with various ischemic vascular territories. These have included pharmacological approaches such as endothelial growth factors, renin-angiotensin-aldosterone system blockade, and If-channel-blockers, as well as interventions like preconditioning, exercise, enhanced external counter-pulsation, and low-energy shock-wave therapy. However, few of these strategies have been implemented in atherosclerotic renovascular disease. This review summarizes current understanding regarding the development of renal collateral circulation in atherosclerotic renovascular disease. Studies are needed to apply lessons learned in other vascular beds in the setting of atherosclerotic renovascular disease to develop new treatment regimens for this patient group.

KW - atherosclerosis

KW - collateral circulation

KW - kidney

KW - prognosis

KW - renal artery

U2 - 10.1161/HYPERTENSIONAHA.121.17960

DO - 10.1161/HYPERTENSIONAHA.121.17960

M3 - Review

C2 - 35135307

VL - 79

SP - 717

EP - 725

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -